Coronavirus Not Impacting Rx Manufacturing Supply Chain – Yet
US FDA’s drug shortage team continues to check in with sponsors, but so far the infections and quarantines have not impacted drug production.
You may also be interested in...
US FDA Puts All China Drug Inspections On Hold Due To Coronavirus Outbreak
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.
For Coronavirus, US FDA Is At The Podium But Not On The Task Force
The FDA is curiously not one of the HHS entities coordinating the US response to the outbreak, but must monitor for manufacturing disruptions and shortages, as well as approve new treatments and diagnostics.
Novel Virus Brings Novel Threats To Global Pharmaceutical Manufacturing
As coronavirus spreads into China’s manufacturing region, quarantines and travel restrictions challenge international flow of pharmaceuticals, ingredients and personnel.